1191244-52-6

Basic information

• Product Name: ethyl 3-(3,5-dibromo-4-hydroxyphenyl)-1,2,4-oxadiazole-5-carboxylate
• Synonyms: ethyl 3-(3,5-dibromo-4-hydroxyphenyl)-1,2,4-oxadiazole-5-carboxylate
• CAS NO: 1191244-52-6
• Molecular Weight: 392.004
• Mol File: 1191244-52-6.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: ethyl 3-(3,5-dibromo-4-hydroxyphenyl)-1,2,4-oxadiazole-5-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3-(3,5-dibromo-4-hydroxyphenyl)-1,2,4-oxadiazole-5-carboxylate(1191244-52-6)
• EPA Substance Registry System: ethyl 3-(3,5-dibromo-4-hydroxyphenyl)-1,2,4-oxadiazole-5-carboxylate(1191244-52-6)

Safety Data

• Hazardous Substances Data: 1191244-52-6(Hazardous Substances Data)

Upstream product

• 1689-84-5 Bromoxynil 
• 875241-38-6 3,5-dibromo-N',4-dihydroxybenzimidamide 
• 4755-77-5 Ethyl oxalyl chloride 

Downstream Products

• 1191252-56-8 3-(3,5-dibromo-4-hydroxyphenyl)-N-(3-(trifluoromethoxy)phenyl)-1,2,4-oxadiazole-5-carboxamide 
• 1191252-59-1 3-(3,5-dibromo-4-hydroxyphenyl)-N-(4-(trifluoromethoxy)benzyl)-1,2,4-oxadiazole-5-carboxamide 
• 1191244-53-7 ethyl 3-(3,5-dibromo-4-(4-methoxybenzyloxy)phenyl)-1,2,4-oxadiazole-5-carboxylate 

Relevant articles and documents

COMPOSITIONS AND METHODS COMPRISING OXADIAZOLE DERIVATIVES

Provided herein are pharmaceutical compositions of compounds of Formula I, metabolites thereof, and pharmaceutically acceptable salts of each thereof containing an effective amount of the compound of Formula I, and methods of their use for treating diarrhea in humans.

Compounds, Compositions and Methods Comprising Oxadiazole Derivatives

The present invention relates to compositions and methods for treating a disease in an animal, which disease is responsive to inhibiting of functional cystic fibrosis transmembrane conductance regulator (CFTR) polypeptide by administering to a mammal in n